The Effect of Biological Effective Dose on Time to Symptom Progression in Metastatic Renal Cell Carcinoma
- 1 October 2003
- journal article
- Published by Elsevier in Clinical Oncology
- Vol. 15 (7) , 400-407
- https://doi.org/10.1016/s0936-6555(03)00164-x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Biological Factors Influencing Optimum Fractionation in Radiation TherapyActa Oncologica, 2001
- Radiotherapy for Metastatic Carcinomas of the Kidney or Melanomas: An Analysis Using Palliative End PointsInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in Vitro and in Vivo in human renal cell carcinoma xenograftsCancer, 1997
- Palliative Irradiation for Focally Symptomatic Metastatic Renal Cell Carcinoma: Support for Dose Escalation Based on a Biological ModelJournal of Urology, 1997
- Effect of L-buthionine sulfoximine on the radiation response of human renal carcinoma cell linesCancer, 1993
- The linear-quadratic formula and progress in fractionated radiotherapyThe British Journal of Radiology, 1989
- Prognostic Factors in Metastatic Renal CarcinomaJournal of Urology, 1986
- Radiation therapy in the treatment of me tastatic renal cell carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1985
- The role of radiation therapy in the management of metastatic renal cell carcinomaCancer, 1983
- Distant metastasis of renal adenocarcinomaCancer, 1981